Browsing Category
Medicine
Pfizer: Pfizer and BioNTech Granted U.S. Emergency Use Authorization for Booster Dose of Their…
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the U.S. Food and Drug Administration (FDA) expanded emergency use authorization (EUA) to include a booster dose after completion of the primary series of the!-->…
Pfizer: Pfizer Presents Positive Real-World Evidence for First-Line IBRANCE® (palbociclib)…
Pfizer Inc. (NYSE:PFE) announced today the presentation of real-world evidence demonstrating an associated benefit for patients treated with IBRANCE® (palbociclib) in combination with an aromatase inhibitor (AI), as compared to AI alone,!-->…
Pfizer: Myovant Sciences and Pfizer Provide Update on Supplemental New Drug Application (sNDA) for…
Myovant Sciences (NYSE: MYOV) and Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for MYFEMBREE® (relugolix 40 mg,!-->…
Johns Hopkins Medicine Researchers Awarded Nearly $8 Million from Break Through Cancer Foundation
The Johns Hopkins Kimmel Cancer Center and the Departments of Gynecology/Obstetrics, Neurosurgery and Pathology have been awarded more than $7.8 million for novel, multicenter projects designed to intercept and find cures for several…
Pfizer: Valneva and Pfizer Report Positive Phase 2 Pediatric Data for Lyme Disease Vaccine Candidate
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and Pfizer Inc. (NYSE: PFE) today reported positive Phase 2 pediatric data for their Lyme disease vaccine candidate, VLA15. Based on these new results, Valneva!-->…
Pfizer: Pfizer and BioNTech Submit Application for U.S. Emergency Use Authorization for a COVID-19…
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today submitted an application to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of a 10-µg booster dose of the Pfizer-BioNTech COVID-19 Vaccine for!-->…
Pfizer: Pfizer and Biohaven’s VYDURA® (Rimegepant) Granted First Ever Marketing Authorization by…
Pfizer Inc. (NYSE: PFE) and Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced that the European Commission (EC) has granted marketing authorization for VYDURA® (rimegepant), a calcitonin gene-related peptide (CGRP)!-->…
Pfizer: Pfizer to Open First U.S. Sites in Phase 3 Trial of Investigational Gene Therapy for…
Pfizer Inc. (NYSE: PFE) announced plans to open the first U.S. sites in the Phase 3 study evaluating the investigational mini-dystrophin gene therapy, fordadistrogene movaparvovec, in ambulatory patients with Duchenne muscular dystrophy!-->…
BLK – Max Super Specialty Hospital, New Delhi organized an exclusive Cancer awareness camp in…
Jodhpur : In an endeavour to bring awareness about the importance of regular health check-ups and early detection, Delhi’s BLK-Max Super Specialty Hospital, organised an exclusive Oncology Health Check Camp in association with the…
Prime Minister Narendra Modi announces ‘Ayush Mark’, Ayush visa category and the enhancement of the…
Gandhinagar : The inaugural session for the first of its kind Global Ayush Investment & Innovation Summit 2022, was held today in the august presence of the Hon’ble Prime Minister Shri Narendra Modi. The Prime Minister announced many…